Physician profile
Rincy Mathai
NPI 1558989665
$493.29
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $73.63 · 2023: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.49 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $208.49 | 2023 | Synchromedii |
| Astrazeneca Pharmaceuticals LP | $50.42 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $31.36 | 2021-2022 | |
| Glaxosmithkline, LLC. | $31.17 | 2021 | |
| Amgen INC. | $28.73 | 2021 | |
| Gilead Sciences, INC. | $28.22 | 2021 | |
| Abbott Laboratories | $22.57 | 2022 | |
| Horizon Therapeutics Plc | $22.44 | 2021 | |
| Ironwood Pharmaceuticals, INC | $19.46 | 2022 | |
| Lilly USA, LLC | $15.10 | 2021 | |
| Abbvie INC. | $14.65 | 2021 | |
| Merck Sharp & Dohme LLC | $14.47 | 2021 | |
| Genentech USA, INC. | $6.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rincy Mathai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.